Contract notice

Information

Published

Date of dispatch of this notice: 26/11/2019

Expire date: 16/01/2020

External Reference: 2019-204724

TED Reference: 2019/S 231-565917

Contract notice

[NoticeContract]

[Directive201424]

[Section1]: [Ca]

I.1)

[NameAddressContact]

Children's Health Ireland
N/A
Dublin 12
Dublin
Ireland
IE
[Contactpoint]: robert keogh
[AddressPhone]: +353 014096598
[AddressEmail]: robert.keogh@olhsc.ie
[Internets]:
[UrlGeneral]: www.chi.ie

I.3)

[InfoTendering]

[AddressObtainDocs]:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=157807&B=ETENDERS_SIMPLE
[AddressFurtherinfo]
[AsContactsAbove]:  
[AddressSendTendersRequest]
[AddressToAbove]
I.4)

[CaType]

[MaintypePublicbody]
I.5)

[Mainactivity]

[MainactivHealth]

[Section2]: [Object]

II.1)

[QuantityScopeContract]

II.1.1)

[TitleContract]

Rituximab or biosimilar
II.1.2)

[CpvMain]

33600000  - 
II.1.3)

[TypeContract]

[Supplies]
II.1.4)

[DescrShort]

We are seeking bids from suitably licensed organisations for the provision of Rituximab (originator or biosimilar) to Children’s Health Ireland.
II.1.5)

[ValueMagnitudeEstimatedTotal]

[ValueExclVat]: 1.00  EUR
II.1.6)

[LotsInfo]

[DivisionLots]: [No]
II.2)

[Description]

II.2.2)

[CpvAdditional]

33600000  - 
II.2.3)

[PlacePerformance]

[MainsiteplaceWorksDelivery]:  
CHI at Crumlin and Temple St
II.2.4)

[DescrProcurement]

We are seeking bids from suitably licensed organisations for the provision of Rituximab (originator or biosimilar) to Children’s Health Ireland.
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.6)

[ValueMagnitudeEstimated]

[ValueExclVat]: 1.00  EUR
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 48
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
Tendered price to remain active for period of 24 months from date of issue.Successful candidates will be obliged to enter into a Service Level Agreement with the Hospital and sign the Hospitals standard SLA. The duration of the contract shall be for an initial 12 month period with an option to roll over for a further 3 periods of 12 month duration.
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [Yes]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]

[Section3]: [InfoLegal]

III.1)

[ConditionsParticip]

III.1.2)

[EconomicFinancialStanding]

[CriteriaSelectionDocs]
III.1.3)

[TechnicalCapacity]

[CriteriaSelectionDocs]
III.2)

[ConditionsContract]

[Section4]: [Procedure]

IV.1)

[Description]

IV.1.1)

[TypeProcedure]

[ProctypeOpen]
IV.1.8)

[GpaInfo]

[GpaCovered] : [No]
IV.2)

[InfoAdmin]

IV.2.2)

[LimitReceiptTendersReqPart]

[Date]:  06/01/2020
[Time]:  12:00
IV.2.4)

[LanguagesAllowed]

[Language_EN]
IV.2.6)

[MinTimeMaintain]

[DateTenderValid]:  31/01/2021
IV.2.7)

[OpeningConditions]

[Date]:  06/01/2020
[Time]:  12:00

[Section6]: [InfoComplement]

VI.1)

[RecurrenceInfo]

[RecurrentProcurement]:  [Yes]
VI.2)

[InfoEworkflow]

[EorderingUsed]
[EinvoicingUsed]
[EpaymentUsed]
VI.4)

[AppealsProcedure]

VI.4.1)

[AppealsBody]

Irish High Court
Dublin
Dublin
IE